Singapore, Oct. 27 -- A United States (US) Government agency has selected Australia's University of Queensland (UQ) researchers to develop technology for personalised RNA medicines to be produced in hospitals, allowing lifesaving treatments to reach patients within days.

UQ's BASE mRNA Facility is part of a consortium of companies, universities and research institutes with potential to receive up to $57 million ($US40 million) funding under the Advanced Research Projects Agency for Health (ARPA-H), an operational division within the US Department of Health and Human Services.

The programme's aim is to build a nationwide network of US hospitals where personalised RNA medicines can be produced on demand, so patients can receive treatment ...